1. United Nations World Tourism Organization. Annual Report. 2015. Web site. http://cf.cdn.unwto.org/sites/all/files/pdf/annual_report_2015_lr.pdf. Accessed December 13, 2016.
2. Boggild AK, Castelli F, Gautret P, et al. Vaccine preventable diseases in returned international travelers: Results from the GeoSentinel Surveillance Network. Vaccine. 2010; 28(46): 7389-7395. doi: 10.1016/j.vaccine.2010.09.009
3. Centers for Disease Control and Prevention. Measles outbreaks. Web site. http://www.cdc.gov/measles/outbreaks.html. Accessed December 13, 2016.
4. Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: Results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007; 44(12): 1560-1568. doi: 10.1086/518173
5. Lau S, Gherardin T. Travel vaccination. Aust Fam Physician. 2007; 36(5): 304-311. Web site. http://search.proquest.com/openview/42f76ed02da0e1e6e6e963dcd101b04c/1?pq-origsite=gscholar&cbl=33668. Accessed December 13, 2016.
6. Virk A, Jong EC. Adult immunizations. In: Keystone JS, Kozarsky PE, Freedman DO, Nothdurft HD, Connor BA, eds. Travel Medicine. Elsevier: Mosby, Spain; 2004: 87-123.
7. Reiter P. Global warming and malaria: Knowing the horse before hitching the cart. Malar J. 2008; 7(Suppl 1): S3. doi: 10.1186/1475-2875-7-S1-S3
8. Sachs J, Malaney P. The economic and social burden of malaria. Nature. 2002; 415(6872): 680-685. doi: 10.1038./415680a
9. World Health Organization. World Malaria Report. 2016. Web site. http://apps.who.int/iris/bitstream/10665/252038/1/9789241511711-eng.pdf?ua=1. Accessed December 13, 2016.
10. Mali S, Steele S, Slutsker L, Arguin PM. Centers for Disease Control and Prevention (CDC). Malaria surveillance-United States, 2006. MMWR Surveill Summ. 2008; 57(SS05): 24-39.
11. Romi R, Sabatinelli G, Majori G. Malaria epidemiological situation in Italy and evaluation of malaria incidence in Italian travelers. J Travel Med. 2001; 8(1): 6-11. doi: 10.2310/7060.2001.5140
12. Malaria. International Travel and Health. Web site. http://www.who.int/ith/ITH2010chapter7.pdf. Accessed December 13, 2016.
13. Ehrhardt S. Malaria. In: Maltezou HC, Gikas A, eds. Tropical and Emerging Infectious Diseases. Kerala, India: Research Signpost; 2010: 147-162.
14. Keystone JS, Steffen R, Kozarsky PE. Health advice for international traveler. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens, and Practice. Philadelphia, USA: Churchill Livingstone Elsevier; 2006: 1400-1424.
15. World Health Organization. International Travel and Health. Web site. http://www.who.int/ith/chapters/ith2012en_chap6.pdf. Accessed December 13, 2016.
16. Centers for Disease Control and Prevention. Web site. http://wwwnc.cdc.gov/travel/destinations/list.htm. Accessed December 13, 2016.
17. Steffen R. Changing travel-related global epidemiology of hepatitis A. Am J Med. 2005; 118 (Suppl 10A): S46-S49. doi: 10.1016/j.amjmed.2005.07.016
18. Mutsch M, Spicher VM, Gut C, Steffen R. Hepatitis A virus infections in travelers, 1988-2004. Clin Infect Dis. 2006; 42(4): 490-497. doi: 10.1086/499816
19. Liu SJ, Sharapov U, Klevens M. Patient awareness of need for hepatitis a vaccination (prophylaxis) before international travel. J Travel Med. 2015; 22(3): 174-178. doi: 10.1111/jtm.12186
20. Pavli A, Spilioti A, Lymperi I, Katerelos P, Maltezou HC. Vaccinations for international travellers travelling from Greece. Travel Med Infect Dis. 2013; 11(4): 225-230. doi: 10.1016/j.tmaid.2012.11.007
21. Pavli A, Katerelos P, Smeti P, Maltezou HC. Meningococcal vaccination for international travellers from Greece visiting developing countries. Travel Med Infect Dis. 2016; 14(3): 261-266. doi: 10.1016/j.tmaid.2016.03.001
22. Pavli A, Maltezou HC. Travel-acquired Japanese encephalitis and vaccination considerations. J Infect Dev Ctries. 2015; 9(9): 917-924. doi: 10.3855/jidc.5108
23. Pavli A, Smeti P, Spilioti A, Vakali A, Katerelos P, Maltezou HC. Descriptive analysis of malaria prophylaxis for travelers from Greece visiting malaria-endemic countries. Travel Med Infect Dis. 2011; 9(6): 284-288. doi: 10.1016/j.tmaid.2011.09.005
24. Schlagenhauf P, Petersen E. Malaria chemoprophylaxis: Strategies for risk groups. Clin Microbiol Rev. 2008; 21(3): 466-472. doi: 10.1128/CMR.00059-07
25. Phillips-Howard PA, Radalowicz A, Mitchell J, Bradley DJ. Risk of malaria in British residents returning from malarious areas. BMJ. 1990; 300(6723): 499–503. doi: 10.1136/bmj.300.6723.499
26. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet. 1993; 341(8856): 1299-1303. doi: 10.1016/0140-6736(93)90814-w
27. Overbosch D, Schilthuis H, Bienzle U, et al. Malarone International Study Team. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: Results from a randomized, double-blind study. Clin Infect Dis. 2001; 33(7): 1015-1021. doi: 10.1086/322694
28. Calleri G, Behrens RH, Bisoffi Z, et al. Variability in malaria prophylaxis prescribing across Europe: A Delphi method analysis. J Travel Med. 2008; 15(5): 294-301. doi: 10.1111/j.1708-8305.2008.00226.x
29. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006; 354(2): 119-130. doi: 10.1056/NEJMoa051331
30. Schlagenhauf P, Petersen E. Standby emergency treatment of malaria in travelers: Experience to date and new developments. Expert Rev Anti Infect Ther. 2012; 10(5): 537-546. doi: 10.1586/eri.12.42
31. Behrens RH, Bisoffi Z, Björkman A, et al. Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent. Malar J. 2006; 5: 7. doi: 10.1186/1475-2875-5-7
32. Gautret P, Schlagenhauf P, Gaudart J, et al. Multicenter Euro TravNet/GeoSentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis. 2009; 15(11): 1783-1790. doi: 10.3201/eid1511.091147
33. Field V, Gautret P, Schlagenhauf P, et al. Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis. 2010; 10: 330 doi: 10.1186/1471-2334-10-330
34. Fenner L, Weber R, Steffen R, Schlagenhauf P. Imported infectious disease and purpose of travel, Switzerland. Emerg Infect Dis. 2007; 13(2): 217-222. doi: 10.3201/eid1302.060847
35. Ericsson CD, Hatz C, Leder K, et al. Illness in travelers visiting friends and relatives: A review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006; 43(9): 1185-1193. doi: 10.1086/507893
36. Angell SY, Cetron MS. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med. 2005; 142(1): 67-72. doi: 10.7326/0003-4819-142-1-200501040-00013
37. Angell SY, Behrens RH. Risk assessment and disease prevention in travelers visiting friends and relatives. Infect Dis Clin North Am. 2005; 19(1): 49-65. doi: 10.1016/j.idc.2004.11.001
38. Pavli A, Katerelos P, Pierroutsakos P, Maltezou HC. Pre-travel counselling in Greece for travelers visiting friends and relatives. Travel Med Infect Dis. 2009; 7(5): 312-315. doi: 10.1016/j.tmaid.2009.07.002
39 Toovey S, Moerman F, van Gompel A. Special infectious disease risks of expatriates and long-term travelers in tropical countries. Part I: Malaria. J Travel Med. 2007; 14(1): 42-49. doi: 10.1111/j.1708-8305.2006.00091.x
40. Barnett ED, MacPherson DW, Stauffer WM, et al. The visiting friends or relatives traveler in the 21st century: Time for a new definition. J Travel Med. 2010; 17(3): 163-170. doi: 10.1111/j.1708-8305.2010.00411.x